(mmHg)

:
,
.

, MD, FESC, FAHA,

;
,
,
.
, ,

,
.

,
,
. .
120 80 mmHg
.
140/90 mmHg
,
130/80 mmHg
.

. ,
.

,

() 110 mmHg
() 130
mmHg.
, ,

, .

04_

95% . ,

.

24,
. , , ,
. ,
, .
(,
),
.
,
,

- ,

.
, , , , ,
,
.

.
.
.

_05



. , , , :
,


,
2,5 .
5

30

, , ,
,

50.000
25%
.

, 37%
25%
.
.

06_

. , ,
,
. , ,
, ,
.
.



.
,

.
, ,
, ,
,
,
.


.
:



,
,


.

, ,
20-30 .

.

,
.


. ,
, ,
, 30-45 , 3-5
.

_07


,
,
,
,

. , ( 30 , 3-5 )
. (
< 25) .
,
.

. ,
(5-10% ) ,
, ,
, ,
.


.
,

- (-
).

.
,
.

08_

,
,
, .

,
,
,
(, ..).
,
. , ,
, .

, ,
,
.
, ,
, ,
:

6 .

2-8 mmHg

8-14 mmHg

( 30 ,
4-9 mmHg
)

(10 )
5-20 mmHg

2-4 mmHg

_09


,
,

.

,
-, ,
,
, ,
1-, .
,
.
( , )
,
, , .

.
,
.
,

.
,
,
. -

10_

, .
, ,
,

.

( -)
- ,
.
,
. -

(
),
.

-, -
- - (). ,

.

(-)

( ACE) -

,
. - .

(-)

, , , ,
,
.
,
-, , .

,
,

. :
.

, ,

. ,
.

10 ,

. , ,
30
.


.

.

1-

,

. , ,
.
.

( )

( ,
), ( ,
) .
.

_11

,

(
).
,

, (),
,
. ,

,
,
.

.

12_

,
, ,
,

. , , ,
,
.
,


.

,
, .

,
.
30 .

,
, .

.
,
,
.


,
.

,
.
,
.
, ,
, .
140/90 mmHg (/),
,
.
-
130/80 mmHg
,
,
, .

,
, ,

,
.
. , 70 160-90
mmHg, , ,
, .
, ,
,
.
,
,
. ,
120 mmHg 130
110.

_13

.

, ,
.

,
. , , .

.

.

.
.

!
.
, , , ,
, .

.
, , , .

,
,
,
.

14_

, ,
.

, . , ,
.

, ,
, .
, !

_15

-
MSc

,
, :

,

.
(
, ).

(<120 mmHg)
(<80 mmHg).
, >140 mmHg
>90 mmHg .

, .

16_

,
.
()
.


, ,
,

DASH.

DASH (Dietary Approaches to

Stop Hypertension, DASH:

)
, . DASH
, ,
, ,
. , ,
, . DASH ,
, 8-14 mmHg,

. ,

,

,

:
,
(: 18,525 Kgr/m2),
( 25
Kgr/m2). ,
94 .
80 .
,
,
. ,

5-10% ( 5-20
mmHg).

_17

N 3 (, , ) 2-3 , (,
).
,
,
.
(
2-3
1-2
).

1 473 ml (
) 1 (25 ml).

,

. , ,


.

2-4 mmHg.

.

.

,
.
,

.
2.000-3.000 mg .
.
,
,
.
, ,
(
6 . ),
2-8 mmHg.

, :
,
.
.
, , , , ,
.
, ( ) ,
, .
, ,
, , , , ,
, . , ,
.

18_

,
. (.. )

, .
,
.


,
,
.
,
,
4,7 . .
, .

.

,
.
,
.

.

,
,

.
, .

_19

 25-30 . .
, , :

.

,
-,
.
(
),
,
, ,
.

, .
5
,
.
,
,
.
.
,
,

, , .

20_

(>4 /)

, , ,
,
, , all-bran

(1-4 /)

T , ,
, ,
, ,

(<1 /)

, ,
, , , ,
, ,

DASH ,

,

. ,
/ ,


.
-3
-6 ( ).

:
:
, ( , , ,
..), (, , , , , ..),
, , , , ..

:
, .
:
, , -3 -6 . (,
, , ,
, , , , , , , ).
, 300-400
mg .
,
.
8-10
[
( , , ..)],
(
).

_21

 (..,
y cola)
. ,
,
.
.
30-60 ,
,
,
,
. , ,

.
.

22_

.


, , ,
, ,
, .


4-9 mmHg.
30 (
10 ). ,

,
,

( ).

DASH

4-5

4-5

4-5

2-3
,

3-6

3
,

A , ,
,

,

_23

 ,

, .
O

, ,
, cottage cheese,

,
,

,
,

,
,
, ,

,
,
.

.

,
,
fast-food,

(
2
,
)

,
.

.
Dressing ()

,
,

(1/4 )

(,
)

(1 ,
30
)

(1 )

,
(
)

(1 ),

( )

, ,

(1 )

(0-100 mg )

(100-200 mg ) (200-300 mg )

(>300 mg )

(1 )

(1/2 )

: 1/2 1
, .

24_

_25

(0-100 mg )

(100-200 mg ) (200-300 mg )

(>300 mg )

(0-100 mg )

(1 ),
(1 )

(6 ,
)

(1 )

(1 )

(1 )

(1 )

(1 )

(1/2 )

(1/2 )

,
,

(1/2 )

(1 ),

(1/2 )

(10 ),

(3
)

(1/2 )

(10 ), (1/2 ), (1/2 ),

(1/2 )
(1 )
(1/2 )

(1/2 )

(1/2
)
(1/2 )

(1
)

,

(1 )

(2 )

(1 )

(

,
100 )

(1 )

,
(5 )

(5 )

(2 . )

1/2

( )

Cottage cheese
(30 .), blue cheese,
,
(30 .)

(1/2 )

(1 )

(1 ),
(1 )

(15 . 1
)

(1/2 )

(1 , 40 .)

(..,
)

(100-200 mg ) (200-300 mg )

(>300 mg )

(1 )

(1 ),

(1 )

(1 ),

(4 )

(2 )

(1 ),
(, 1 : 25 .)

(2
)

(60 ml),
(1 )

(1 ),

26_

_27

, , ,
, , ,
, , .
, , . , ,
, . .

,
.

, ,
(2
)
). .
.

, , .
, . ,
(>10%).
(40% ) .
(.., , , ,
, , , blue-cheese, ,
). .

(2%),
cottage (4% ),

(2% 4% ).`

( 1,5% ).
(0-2%),

,
,
, cottage
(1-2%).

,
,
(dips).

,
,
, , .

, ( ) .
.
.

,
. .
.

,
,

.
3 . .

, ,
, .
, , .
,
.
,
- .
.

(, ,
),
, .

, , .

(.., , ..)

, . ,
, cola.

( ).

(, , ,
), ,
(> 10%),
( ).

, ,
( ).

(
): , ,
, .
(dressing)
.
.

, , , .

, .

, ,
.

(, , ),
(, ,
..).

http://www.nhlbi.nih.gov/health/public/heart/hbp/dash/new_dash.pdf He FJ, MacGregor GA.

Potassium intake and blood pressure. Am J Hypertens 1999 August;12(8 Pt 1):849-51. onId=321&parentSection
=299&which=1. Accessed2007. Mancia G, De BG, Dominiczak A et al. 2007 Guidelines for the Management
of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of
Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007 June;25(6):1105-87.
28_

Hypertension: management of hype rtension in adults in primary care. NICE/BHS Hypertension Guideline Review 28 June 2006 World Health Organisation (WHO)/International Society for Hypertension (ISH). Statement
on management of hypertension. Journal of Hypertension 2003 21:1983-1992 The Information Centre (2006)
Health Survey for England 2005. Latest trends. See http://www.ic.nhs.uk/pubs/hseupdate05/tabs/file.
www.usda.org
_29

... , ;
-
&
E

(4-5 )
1
4
3
1

2
2

, ,
. ,
,
, ,
.

.
,
,

.

(2 )
250 ( )
(
)
200
( 100
)
2
4
3
5

1
1
4
(,
)

30_

.
.
,
, .
, . ,
, ,
. ,
,
.
, ,
.
,
,
1-2
.
,
. ,
,
.
.
_31

(4-5 )
1/2
1/2
( 4 )
1

1

2
1

1
1

, ,
,
.

,
,

.
.

(6 )
4
( 800 .)

-
,
4 ,
,
.
.

1
2

2

30

. ,
.
.
, , ,
, ,
, .
(
)
.
,
.

6
2

5-6
32_

_33

I
. - . ..
1, , 14451
.: 210 2718360, fax: 210 2718542

KProvoli
21, , 14231
.: 210 2715032, fax: 210 2714437

MARKETING & SALES MANAGER

CREATIVE DIRECTOR

, MD, FESC, FAHA,

-, MSc

34_

_35

36_